Company Spotlight

ReelCardio.com | ReelECG™

Real-Time Continuous AECG monitoring Technologies

ReelCardio is pleased to introduce their newest ReelECG™ambulatory Cardiac Monitor called the ReelWearable+ Plus. The ReelWearable+ Plus  is one of a kind ambulatory cardiac (AECG) monitoring technology in that it is flexible in its clinical use, applications & monitoring capabilities. ReelECG™ Monitoring is Real-Time, Continuous Ambulatory ECG device that is capable of performing all forms of ambulatory cardiac (AECG) monitoring.

ReelECG™ & ReelWearable+ Plus monitoring modalities include:  

• 24-Hour Holter Monitoring
• Extended Holter Monitoring (up to 7 days)
• Cardiac Event Monitoring (CEM Up to 30 Days
• Mobile Cardiac Telemetry (MCT) Monitoring (3-30 days)
• Cardiac Implantable Electronic Devices (CIED) Monitoring
• Remote Patient / Physiological Monitoring (RPM is 30 minutes of ECG each month)

ReelECG™ technology has many distinct advantages compared to other AECG monitors on the market as we the ReelWearable+ Plus provides maximum versatility in application, modality and custom monitoring vectors ( adjustable 1-2 channel) versions are available. ReelECG™ offers maximum convertibility in that it can be used as a re-usable monitor as well as a re-usable patch configuration called the ReelECG™ ReelPatch+ Plus.

The ReelECG™ ReelPatch+ Plus is extremely cost effective compared to other single use, disposable patches.  The ReelCardio ReelECG™ Patch is re-usable with our inexpensive ECG electrodes. Further, the ReelECG™ ReelPatch+ Plus is flexible in its application to maximize the optimal ECG lead placement / vector to enhanced the clinical findings. Most patches are very limited in their application making some of the ECG data unverifiable.

ReelCardio’s ReelECG™ technology captures continuous Ambulatory ECG data and transmits / sends in (near) real-time to the ReelCardio Laboratory. ReelECG™ is a unique & proprietary blend of continuous ECG data that instantaneously sends every beat of ECG data  to ensure everything is reviewed by a Certified Electrocardiographic Technician. Our signature ‘REEL’ is a patent pending formula understood as our unique method of Real-time | External | Electrocardiographic | Language (REEL) for directly capturing real time ECG data and sent directly from our single, integrated ReelECG™ module. With ReelECG™, there is an integrated cellular phone that eliminates the needs for a separate gateway device or cellular phone. Our ReelECG™ module offers both single & dual channel configurations. Plus, there is selective sampling rate to accommodate the most sophisticated rates, rhythms & pacer detection. ReelECG is not only preferred in Cardiology, but also the electrophysiology (EP), pediatric Electrophysiology & the clinical trial space.

For more details on our continuous ReelECG™ method, please visit Mobile Cardiac Telemetry (MCT) with ReelCardio’s ReelECG.

Other Links:

• ReelECG.com
• ReelWearable.com
• ReelMonitor.com
• ReelHolter.com
• ReelPatch.com
• Download ReelECG Web Brochure
• ReelCardio Monitoring Services
• Billing & Reimbursement Structures
• Free Trial for ReelWearable+ Plus Monitor

For questions or interest, please call (817) 936-8181 or email us at Sales@ReelCardio.com.

---

AutonomicDysfunction.com

ANS | Sudomotor Response | Vascular

Our featured company is called AutonomicDysfunction.com. Autonomicdysfunction.com is a new platform providing information for physicians & medical professionals about autonomic nervous system (ANS) & sudomotor testing.  The autonomic nervous system (ANS) communicates with the brain sending signals via nerves to regulate heart rate, blood pressure, vasomotor function & peripheral arterial pressures. Autonomic dysfunction (over time) is known to lead to cardiac arrhythmias, resting tachycardia and other electrical instabilities. Further, these electrical instabilities can result in mechanical dysfunction in the heart.

ANS testing is a useful tool for cardiovascular clinicians because both branches of the autonomic nervous system initiate the electrical and the mechanical functions of the heart. ANS testing is measured by monitoring Heart Rate Variability (HRV) which closely monitors the variation of time in between each heart beat. Heart Rate Variablity (HRV) monitoring is a complex method of utilizing low & high frequencies to assess the hearts ability to increase or decrease when needed.  Clinical Studies over the last 25 years have linked low HRV with increased risk of adverse cardiovascular events and even mortality from sudden death.

ANS testing with AutonomicDysfunction.com is unique compared to other methods of measuring the autonomic nervous system because it combines heart rate variability (HRV), beat by beat blood pressure as well as sudomotor function into one study. Sudomotor (sweat) testing has been proven to be cost effective and accurate method of assessing the autonomic nerves that innervate the hands and feet. Sudomotor function is a quick and painless test to assess the severity and distribution of autonomic neuropathy which often starts in the most distal parts of the body and spreads proximal.  Sudomotor testing with heart rate variability is (arguably) one of the most powerful diagnostic tools for assessing cardiac autonomic neuropathy which represents one of the greatest risk factors of sudden cardiac death.

Summary of Information from ANS testing include:

• Heart Rate Variability
  • Sympathetic activity / response
  • Parasympathetic activity / response
• Autonomic balance
• Microvascular circulation
• Arterial stiffness
• Systemic vascular resistance
• Stroke volume
• Cardiac output
• Pre-Ejection Period
• Acceleration Index
• Endothelial function
• Inflammation
• Identify severity & distribution of various forms of neuropathy such as peripheral neuropathy & cardiac autonomic neuropathy (CAN)

Recommended Use of Autonomic Nervous System (ANS) Testing:

• Autonomic disorders in patients with diabetes & cardiovascular disease
• Blood pressure disorders
• Resting tachycardia
• Postural Tachycardia Syndrome (POTS)
• Neurocardiogenic syncope
• Dosing of beta blocker therapy
• Assess patient response to various drug therapies
• Cardiac Autonomic Neuropathy (CAN)
• Diabetic Autonomic Neuropathy
• Peripheral Neuropathy
• Monitor disease progression
• Assess patient response to therapy

ANS testing is a simple 7 minute test with no supply or disposable costs. The national average reimbursement is approximately $300 per study from Medicare. For more information, please visit the website www.AutonomicDysfunction.com or email sales@anstesting.com

Sponsored Ad